Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study

BACKGROUND: In Europe, administration of an inhaled corticosteroid (ICS) combined with a long-acting β2 agonist is approved in chronic obstructive pulmonary disease (COPD) patients with a pre-bronchodilator FEV(1) < 60% predicted normal, a history of repeated exacerbations, and who have significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Roche, Nicolas, Pribil, Céline, Van Ganse, Eric, Serrier, Philippe, Housset, Bruno, Poirier, Déborah, Texier, Nathalie, Schück, Stéphane, Boucot, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997842/
https://www.ncbi.nlm.nih.gov/pubmed/24694050
http://dx.doi.org/10.1186/1471-2466-14-56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997842/
https://www.ncbi.nlm.nih.gov/pubmed/24694050
http://dx.doi.org/10.1186/1471-2466-14-56

Ejemplares similares